Delivery Order SPE2DB22D9353-SPE2DB25FX1NE

Award Date 11/27/24
Potential Completion Date 12/19/24
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,254.96 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that the DLA awarded to DMS Pharmaceutical Group to provide a comprehensive range of pharmaceutical products, including common medications, specialized drugs, and...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $134,458.52 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, which runs through December 30, 2024, is for the provision of a diverse range of pharmaceutical products and medical supplies, including branded and generic prescription drugs, over-the-counter medications, biologics, and specialty items, to support the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $14,347.75 contract is for the provision of a broad range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract, valued at $18,397.58, to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, which runs through November 2024, is for the procurement of a variety of pharmaceutical products and medical supplies, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical needs of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $25,868.10, is for the delivery of a variety of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA,...
The U.S. government's Defense Logistics Agency (DLA) awarded a Delivery Order contract, valued at $80,285.70, to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. This Delivery Order is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $499,999,999, which provides a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. The contract...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $46,683.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product, with an ultimate completion date of August 9, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $16,846.92 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of various pharmaceutical products, including branded and generic medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities worldwide. This delivery order is part of a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $6,347.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of various pharmaceutical products and medical supplies to support the medical supply needs of military health facilities nationwide. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under...
The U.S. government's Defense Logistics Agency (DLA) awarded a $15,524.40 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order was issued under the DLA's SPE2DB indefinite delivery contract (IDC), a single-award vehicle valued at up to $499,999,999 that runs through December 31, 2025. The contract is for the supply of a wide range of pharmaceutical products, including...
  • SPE2DB22D9353
    Indefinite Delivery Contract
  • SPE2DB22D9353-SPE2DB25FX1NE
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $17,050.83 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of SUSVIMO 10 MG/0.1 ML VIAL 0.1ML, a specialized pharmaceutical product, with a performance period ending on December 19, 2024. This award is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.

Generated 2/26/25, 9:53 AM